Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
We analyzed data from the National Nosocomial Infections Surveillance (NNIS) System from 1986-2003 to determine the epidemiology of gram-negative bacilli in intensive care units (ICUs) for the most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI). We analyzed >410,000 bacterial isolates associated with hospital-acquired infections in ICUs during 1986-2003. In 2003, gram-negative bacilli were associated with 23.8% of BSIs, 65.2% of pneumonia episodes, 33.8% of SSIs, and 71.1% of UTIs. The percentage of BSIs associated with gram-negative bacilli decreased from 33.2% in 1986 to 23.8% in 2003. The percentage of SSIs associated with gram-negative bacilli decreased from 56.5% in 1986 to 33.8% in 2003. The percentages pneumonia episodes and UTIs associated with gram-negative bacilli remained constant during the study period. The proportion of ICU pneumonia episodes associated with Acinetobacter species increased from 4% in 1986 to 7.0% in 2003 (P<.001, by the Cochran-Armitage chi2 test for trend). Significant increases in resistance rates were uniformly seen for selected antimicrobial-pathogen combinations. Gram-negative bacilli are commonly associated with hospital-acquired infections in ICUs. The proportion of Acinetobacter species associated with ICU pneumonia increased from 4% in 1986 to 7.0% in 2003.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a group, these organisms are the most common etiology of nosocomial infections, including most cases of hospital-acquired pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia, and they are important causes of morbidity and death in hospitalized patients (1).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [1]
Citations
Cites
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationSurveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Epidemiology and control of nosocomial infections in adult intensive care units
Weinstein, R. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90366-6 · Cited by 300 · cited 1×
“the 4 most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI) [1].”
BackgroundSelf-citationMultidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285 · cited 1×
“Acinetobacter organisms are intrinsically resistant to many antimicrobials and can acquire resistance to others [7].”
BackgroundHOSPITAL ACQUIRED INFECTIONS: KNOWLEDGE ABOUT IT AND ITS PREVENTION
QAYYUM, S., WAQAS, B., & SATTAR, A. (2010) · The Professional Medical Journal · doi:10.29309/tpmj/2010.17.02.2211 · Cited by 256
MAGNITUDE AND PREVENTION OF NOSOCOMIAL INFECTIONS IN THE INTENSIVE CARE UNIT
Fridkin, S. K., Welbel, S. F., & Weinstein, R. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70366-4 · Cited by 225 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
BackgroundSelf-citationStreit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Syncope and orthostatic hypotension
Atkins, D., Hanusa, B., Sefcik, T., & Kapoor, W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90012-m · Cited by 172
Research works printed but not linked: 2
- 1991, The American journal of medicine, 91, 86
- Richards, 2003, Annals of surgery, 237, 358, 10.1097/00000658-200303000-00009 · doi:10.1097/00000658-200303000-00009
Cited by
Items 401–500 of 1,000
The Role of Antimicrobial Stewardship in Curbing Carbapenem Resistance
Bogan, C., & Marchaim, D. (2013) · Future Microbiology · doi:10.2217/fmb.13.73 · Cited by 45
He, C., Zhou, Y., Liu, F., Liu, H., Tan, H., Jin, S., Wu, W., & Ge, B. (2017) · Infection and Immunity · doi:10.1128/iai.00239-17 · Cited by 37
Hassan, N., Awdallah, F. F., Abbassi, M., & Sabry, N. A. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002695 · Cited by 45
Fernando, D. M., Zhanel, G. G., & Kumar, A. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/696043 · Cited by 42
“Outbreaks in hospitals have been reported from various geographical areas (5), and the incidence of A baumannii-mediated infection has been increasing steadily over the past two decades (6).”
BackgroundKyaw, M. H., Kern, D. M., Zhou, S., Tunceli, O., Jafri, H. S., & Falloon, J. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-0917-x · Cited by 41
Synergy Potential of Indole Alkaloids and Its Derivative against Drug‐resistant Escherichia coli
Dwivedi, G. R., Gupta, S., Maurya, A., Tripathi, S., Sharma, A. K., Darokar, M. P., & Srivastava, S. K. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12613 · Cited by 41
“10-Methoxytetrahydroalstonine (1) Isoreserpiline (2)”
BackgroundMethodInfluentialHuman Pathogenic Enterobacteriaceae
Rock, C. O., & Donnenberg, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00136-7 · Cited by 44
The role of 2,4-dihydroxyquinoline (DHQ) in Pseudomonas aeruginosa pathogenicity
Gruber, J. D., Chen, W., Parnham, S. R., Beauchesne, K. R., Moeller, P. D. R., Flume, P. A., & Zhang, Y. (2016) · PeerJ · doi:10.7717/peerj.1495 · Cited by 41
Amin, M., Navidifar, T., Shooshtari, F. S., & Goodarzi, H. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s196575 · Cited by 41
Heterogeneous Strategies to Eliminate Intracellular Bacterial Pathogens
Liu, Y., Jia, Y., Yang, K., & Wang, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00563 · Cited by 42
“The released endonuclease G (EndoG) or apoptosis inducing factor (AIF) would directly bring about apoptotic death by caspaseindependent pathway (Li et al., 2001; Xiaochen et al., 2002).”
BackgroundJones, R. A., Shropshire, H., Zhao, C., Murphy, A. R. J., Lidbury, I. D. E. A., Wei, T., Scanlan, D. J., & Chen, Y. (2021) · The ISME Journal · doi:10.1038/s41396-021-01008-7 · Cited by 41
Antimicrobial Susceptibility Profile of Pseudomonas aeruginosa Isolates in Egypt
Gad, G. F. M., El-Domany, R. A., & Ashour, H. M. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.03.081 · Cited by 41
Epidemiology of nosocomial bloodstream infections in Estonia
Mitt, P., Adamson, V., Lõivukene, K., Lang, K. M. H., Telling, K., Päro, K., Rõõm, A., Naaber, P., & Maimets, M. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.01.008 · Cited by 41
Moland, E. S., Craft, D. W., Chong, Y., Kim, S.-Y., Hachmeister, L., Sayed, S. D., & Thomson, K. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-07 · Cited by 41
Palliyil, S., Downham, C., Broadbent, I. D., Charlton, K. A., & Porter, A. J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02912-13 · Cited by 41
“aeruginosa is the second most common cause of health care-associated pneumonia and the leading cause of pneumonia in pediatric patients in intensive care units (1, 2).”
BackgroundHealth care–associated pneumonia: identification and initial management in the ED
Abrahamian, F. M., DeBlieux, P. M. C., Emerman, C. L., Kollef, M. H., Kupersmith, E., Leeper, K. V., Paterson, D. L., & Shorr, A. F. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.03.015 · Cited by 44
“The situation is further complicated by the rapid emergence of multidrug-resistant (MDR) pathogens and their increased prevalence in the community [5].”
BackgroundSzabó, D., Szentandrássy, J., Juhasz, Z., Katona, K., Nagy, K., & Rókusz, L. (2008) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-7-12 · Cited by 41
Prosthetic knee infection by resistant bacteria: the worst‐case scenario
Vasso, M., Panni, A. S., Martino, I. D., & Gasparini, G. (2016) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-016-4010-8 · Cited by 41
MacDonald, E. A., Handeland, K., Blystad, H., Bergsaker, M. A. R., Fladberg, M., Gjerset, B., Nilsen, O., Os, H., Sandbu, S., Stokke, E., et al. (2011) · Eurosurveillance · doi:10.2807/ese.16.40.19985-en · Cited by 40
Verma, V., & Kandasubramanian, B. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.04.061 · Cited by 40
Jeong, S. J., Yoon, S. S., Bae, I. K., Jeong, S. H., Kim, J. M., & Lee, K. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.003 · Cited by 40
“Carbapenem resistance in P. aeruginosa has been reported to have increased steadily over the years (Gaynes and Edwards, 2005; Livermore, 2002).”
BackgroundRaible, K. M., Sen, B., Law, N., Bias, T. E., Emery, C. L., Ehrlich, G. D., & Joshi, S. G. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-017-0248-3 · Cited by 40
“baumannii to rapidly gain resistance to antimicrobial compounds is an important populationlevel virulence factor [12] for the successful dissemination of the organism within and among health-care facilities [13, 14].”
BackgroundGuideline for the diagnosis, prevention and treatment of paediatric ventilator-associated pneumonia.
Morrow, B. M., Argent, A. C., Jeena, P. M., & Green, R. J. (2009) · PubMed · Cited by 51
Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients
Caricato, A., Montini, L. M., Bello, G., Michetti, V., Maviglia, R., Bocci, M. G., Mercurio, G., Maggiore, S. M., & Antonelli, M. M. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1582-5 · Cited by 39
Kwon, K. H., Oh, J. Y., Yoon, Y.-S., Jeong, Y., Kim, K. S., Shin, S. J., Chung, J., Huh, H. J., Chae, S. L., & Park, S. Y. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.01.011 · Cited by 42
“baumannii (CRAB) is a significant pathogen causing nosocomial infections [8].”
BackgroundInfluentialLanjri, S., Uwingabiye, J., Frikh, M., Abdellatifi, L., Kasouati, J., Maleb, A., Bait, A., Lemnouer, A., & Elouennass, M. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0195-y · Cited by 40
Ayelign, B., Abebe, B., Shibeshi, A., Meshesha, S., Shibabaw, T., Addis, Z., Gelaw, A., & Dagnew, M. (2017) · Urology Research and Practice · doi:10.5152/tud.2017.33678 · Cited by 39
Muntean, D., Horhat, F. G., Bădițoiu, L., Dumitraşcu, V., Bagiu, I. C., Horhat, D. I., Cosnita, A., Krasta, A., Dugăeșescu, D., & Licker, M. (2018) · Medicina · doi:10.3390/medicina54060092 · Cited by 39
Omokhua, A. G., Abdalla, M. A., Leonard, C. M., Aro, A. O., Uyi, O., Staden, J. V., & McGaw, L. J. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03024-0 · Cited by 40
“This implies that the isolated compounds may be useful in the treatment of UTIs caused by the investigated strains, without much fear of safety [8, 85, 86].”
BackgroundMiao, J., Chen, F., Duan, S., Gao, X., Liu, G., Chen, Y., Dixon, W., Xiao, H., & Cao, Y. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00678 · Cited by 39
Asensio, Á., Álvarez-Espejo, T., Navajas, J. F.-C., Ramos, A., Vaqué, J., Bishopberger, C., Navarrete, M. J. H., Calbo, F., García‐Campayo, J., Cantón, R., et al. (2011) · Eurosurveillance · doi:10.2807/ese.16.40.19983-en · Cited by 39
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.08.001 · Cited by 44
Özer, B., Duran, N., Önlen, Y., & Savaş, L. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.102 · Cited by 39
Wallace, S. J., Li, J., Nation, R. L., Prankerd, R. J., & Boyd, B. J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23203 · Cited by 39
Blood culture systems: rapid detection – how and why?
Gaibani, P., Rossini, G., Ambretti, S., Gelsomino, F., Pierro, A. M., Varani, S., Paolucci, M., Landini, M. P., & Sambri, V. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70559-x · Cited by 39
Sonmezer, M. C., Ertem, G. T., Erdinç, F. Ş., KILIÇ, E. K., Tülek, N., Adiloğlu, A. K., & Hatipoğlu, Ç. A. (2016) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2016/1321487 · Cited by 39
Acanthamoeba sp. promotes the survival and growth of Acinetobacter baumanii
Cateau, E., Verdon, J., Fernandez, B., Héchard, Y., & Rodier, M. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02261.x · Cited by 39
Blanc, D., Magalhães, B., Abdelbary, M. M. H., Prod’hom, G., Greub, G., Wasserfallen, J., Genoud, P., Zanetti, G., & Senn, L. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.02.010 · Cited by 38
Rezaei, M., Dadgar, Z., Noori-Zadeh, A., Mesbah‐Namin, S. A., Pakzad, I., & Davodian, E. (2015) · PubMed Central · Cited by 38
for the iDIAPASON study group, Bouglé, A., Foucrier, A., Dupont, H., Montravers, P., Ouattara, A., Kalfon, P., Squara, P., Simon, T., & Amour, J. (2017) · Trials · doi:10.1186/s13063-017-1780-3 · Cited by 39
Duda-Madej, A., Kozłowska, J., Krzyżek, P., Anioł, M., Seniuk, A., Jermakow, K., & Dworniczek, E. (2020) · Molecules · doi:10.3390/molecules25163642 · Cited by 38
Hospital acquired infections in a medical intensive care unit.
Akhtar, N. (2010) · PubMed · Cited by 38
Ledizet, M., Murray, T. S., Puttagunta, S., Slade, M. D., Quagliarello, V., & Kazmierczak, B. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049578 · Cited by 38
Heteroresistance to Meropenem in Carbapenem-Susceptible Acinetobacter baumannii
Ikonomidis, A., Neou, E., Gogou, V. A., Vrioni, G., Tsakris, A., & Pournaras, S. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00959-09 · Cited by 38
Håkansson, J., Björn, C., Lindgren, K., Sjöström, E., Sjöstrand, V., & Mahlapuu, M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-14 · Cited by 38
van Os, W., & Zeitlinger, M. A. (2021) · Antibiotics · doi:10.3390/antibiotics10121485 · Cited by 40
“Being the most common foci of infection, drug penetration into the lungs, urinary tract, skin and soft tissues deserve particular consideration [31].”
BackgroundSobel, J. D., & Kaye, D. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00074-6 · Cited by 61
Vahdani, P., Yaghoubi, T., & Aminzadeh, Z. (2011) · PubMed Central · Cited by 37
Walkty, A. J., Karlowsky, J. A., Adam, H. J., Baxter, M. R., Lagacé-Wiens, P. R. S., Hoban, D. J., & Zhanel, G. G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01404-13 · Cited by 37
Antibacterial effects of oregano (Origanum vulgare) against gram negative bacilli
Chaudhry, N., Saeed, S., & Tariq, P. (2007) · Pakistan Journal of Botany · Cited by 37
Bactericidal assessment of nano-silver on emerging and re-emerging human pathogens
Anuj, S. A., Gajera, H. P., Hirpara, D. G., & Golakiya, B. A. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.04.028 · Cited by 37
Rteil, A., Kazma, J. M., Sawda, J. E., Gharamti, A. A., Koubar, S. H., & Kanafani, Z. A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.01.314 · Cited by 37
Bustamante-Torres, M., Pino-Ramos, V. H., Romero-Fierro, D., Bonilla, S. P. H., Magaña, H., & Bucio, E. (2021) · Polymers · doi:10.3390/polym13142223 · Cited by 38
“Bacterial infections are caused by either gram-positive or gram-negative microorganisms, leading to widespread mortality and the overload of the global medical system [14,15].”
BackgroundGram-negative bacterial pneumonia: aetiology and management
Koulenti, D., & Rello, J. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.mcp.0000219269.73180.5d · Cited by 37
Ertapenem: No effect on aerobic gram-negative susceptibilities to imipenem
Goff, D. A., & Mangino, J. E. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.06.001 · Cited by 37
Effect of oral hygiene interventions on opportunistic pathogens in patients after stroke
Lam, O., McMillan, A. S., Samaranayake, L. P., Li, L. S. W., & McGrath, C. P. J. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.02.020 · Cited by 37
Dwivedi, G. R., Tiwari, N., Singh, A., Kumar, A., Roy, S., Negi, A. S., Pal, A., Chanda, D., Sharma, A. K., & Darokar, M. P. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7152-6 · Cited by 37
Bouguenoun, W., Bakour, S., Bentorki, A. A., Al-Bayssari, C., Merad, T., & Rolain, J. (2016) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.08.011 · Cited by 40
Aminoglycoside-associated acute kidney injury in elderly patients with and without shock
Ong, L., Tambyah, P. A., Lum, L. H.-W., Low, Z.-J., Cheng, I., Murali, T. M., Wan, M.-Q., & Chua, H. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw296 · Cited by 36
Raba, D. A., Rosas‐Lemus, M., Menzer, W. M., Li, C., Fang, X., Liang, P., Tuz, K., Minh, D. D. L., & Juárez, O. X. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003194 · Cited by 38
Anti-biofilm and anti-virulence effects of zerumbone against Acinetobacter baumannii
Kim, H., Shin, D.-S., Jang, H.-I., & Eom, Y. (2020) · Microbiology · doi:10.1099/mic.0.000930 · Cited by 36
Siddiqui, N. U. R., Qamar, F. N., Jurair, H., & Haque, A. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0626-9 · Cited by 36
“Acinetobacter species that are drug resistant and hence difficult to treat are increasingly being reported [26-28].”
BackgroundAn exploration of the psychologic impact of contact isolation on patients in Singapore
Soon, M. M. L., Madigan, E. A., Jones, K. R., & Salata, R. A. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.01.037 · Cited by 41
Kwon, S. H., Ahn, H. L., Han, O. Y., & La, H. O. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00109 · Cited by 36
Benner, K. W., Prabhakaran, P., & Lowros, A. S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.2.83 · Cited by 36
Comparison of 2002–2006 OPTAMA Programs for US Hospitals: Focus on Gram-Negative Resistance
Crandon, J. L., Kuti, J. L., Jones, R. N., & Nicolau, D. P. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l473 · Cited by 38
Tartof, S. Y., Kuntz, J. L., Chen, L. H., Wei, R. X., Puzniak, L., Tian, Y., Im, T. M., Takhar, H. S., Merchant, S., & Lodise, T. P. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3927 · Cited by 41
Ramirez, M. S., Vilacoba, E., Stietz, M. S., Merkier, A. K., Jeric, P., Limansky, A. S., Márquez, C., Bello‐Toledo, H., Catalano, M., & Centrón, D. (2013) · Current Microbiology · doi:10.1007/s00284-013-0326-5 · Cited by 35
“Over the past years, multidrug resistant Acinetobacter baumannii (MDRAb) isolates have been reported with increasing frequency, being mainly related to nosocomial infections [9, 18].”
Adegoke, A. A., Tom, M., & Okoh, A. I. (2012) · Journal of Basic Microbiology · doi:10.1002/jobm.201100323 · Cited by 35
“They also have high precedence of antibiotic resistance which is expressed in cases of nosocomial infection and makes their dissemination to be of immense concern to the clinician [10].”
BackgroundThe role of IL-1β in Pseudomonas aeruginosa in lung infection
Wonnenberg, B., Bischoff, M., Beißwenger, C., Dinh, T., Bals, R., Singh, B., & Tschernig, T. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2387-9 · Cited by 35
“Pseudomonas aeruginosa is an opportunistic human pathogen and a major cause of nosocomial infections (Gaynes and Edwards 2005).”
BackgroundHundeshagen, G., Herndon, D. N., Capek, K. D., Branski, L. K., Voigt, C. D., Killion, E. A., Cambiaso‐Daniel, J., Sljivich, M., Crescenzo, A. D., Mlcak, R. P., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1899-3 · Cited by 39
“lence of multidrug-resistant organisms has been steadily increasing [6, 7], limiting antibiotic treatment options for”
BackgroundChang, Y.-T., Siu, L.-K. K., Wang, J., Wu, T., Chen, Y., Chuang, Y.-C., Lin, J., & Lu, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s208231 · Cited by 35
Profile of Enterobacteria Resistant to Beta-Lactams
Santos, A. L., dos Santos, A. P., Ito, C. R. M., de Queiroz, P. H. P., de Almeida, J. A., Júnior, M. A. B. D. C., de Oliveira, C. Z., Avelino, M. A. G., Wastowski, I. J., Gomes, G. P. L. A., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9070410 · Cited by 37
Hsieh, Y., Wang, S., Chen, Y., Lin, T., Shie, S., Huang, C., Lee, C., Chen, Y.-C., Quyen, T. L. T., & Pan, Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1822757 · Cited by 35
Attapulgite Doped with Fe and Cu Nanooxides as Peroxidase Nanozymes for Antibacterial Coatings
Feng, F., Zhang, X., Mu, B., Wang, P., Chen, Z., Zhang, J., Zhang, H., Zhuang, J., Zhao, L., An, Q., et al. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c03721 · Cited by 35
Thorn, K. A., Maragakis, L. L., Richards, K., Johnson, J. K., Roup, B., Lawson, P., Harris, A. D., Fuss, E. P., Pass, M. A., Blythe, D., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1017/s0195941700031489 · Cited by 35
Dryden, M. (2008) · Surgical Infections · doi:10.1089/sur.2008.066.supp · Cited by 44
Shelburne, S. A., Singh, K. V., White, A. C., Byrne, L., Carmer, A., Austin, C., Graviss, E. A., Stager, C. E., Murray, B. E., & Atmar, R. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01459-07 · Cited by 35
“Acinetobacter baumannii is a gram-negative bacterium that is increasingly being identified as a significant cause of serious antibiotic-resistant nosocomial infections, especially in the intensive care unit (ICU) setting (12, 15 , 31, 34).”
BackgroundTozzo, P., Delicati, A., & Caenazzo, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.989496 · Cited by 39
on behalf of the Antibiotic Resistance Surveillance Group, Croughs, P. D., Ли, Б., Hoogkamp-Korstanje, J. A. A., & Stobberingh, E. E. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1741-4 · Cited by 34
Slama, T. G. (2008) · Critical Care · doi:10.1186/cc6994 · Cited by 34
“An analysis of data from the National Nosocomial Infections Surveillance system between 1986 and 2003 examined trends in the epidemiology of Gram-negative infections in ICUs [ 10 ].”
BackgroundMethodNemeth, J., Ledergerber, B., Preiswerk, B., Nobile, A., Karrer, S., Ruef, C., & Kuster, S. P. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.08.017 · Cited by 34
Population Dynamics of an Acinetobacter baumannii Clonal Complex during Colonization of Patients
Wen, H., Wang, K., Liu, Y., Tay, M., Lauro, F. M., Huang, H., Wu, H., Liang, H., Ding, Y., Givskov, M., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-14 · Cited by 34
Lim, T.-P., Ledesma, K. R., Chang, K., Hou, J., Kwa, A. L., Nikolaou, M., Quinn, J. P., Prince, R. A., & Tam, V. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01309-07 · Cited by 34
Risk factors associated with postcraniotomy meningitis: A retrospective study
Chen, C., Chang, C.-Y., Lin, L.-J., Chen, W., Chang, Y., Wang, S., Cheng, C., & Yen, H.-C. (2016) · Medicine · doi:10.1097/md.0000000000004329 · Cited by 34
Tiwari, V., Nagpal, I., Subbarao, N., & Moganty, R. R. (2012) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1346-3 · Cited by 33
Le, H. N., Tran, V. G., Vu, T. T. T., Gras, E., Le, V. T. M., Pinheiro, M. G., Aguiar-Alves, F., Schneider-Smith, E., Carter, H. C., Sellman, B. R., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00710-19 · Cited by 33
Sun, P., Xia, W., Liu, G., Huang, X., Tang, C., Liu, C., Xu, Y., Ni, F., Mei, Y., & Pan, S. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s225546 · Cited by 33
“Escherichia coli is a member of the human gut microbiota and is one of the most common gram-negative bacteria isolated from hospital specimens such as urine, fecal, sputum and bloodstream.(9) In addition, Escherichia coli also plays an important role in community-acquired urinary tract infectious disease.”
BackgroundEmergence of Multidrug- and Pandrug- Resistant Pseudomonas aeruginosa from Five Hospitals in Qatar
Ahmed, M. A. S., Hassan, A., Jarir, S. H. A., Hadi, H. A., Bansal, D., Wahab, A. A., Muneer, M., Mohamed, S., Zahraldin, K., Hamid, J., et al. (2019) · Infection Prevention in Practice · doi:10.1016/j.infpip.2019.100027 · Cited by 33
Ezzedine, J., Desdevises, Y., & Jacquet, S. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1979464 · Cited by 33
“2017), and they are often associated with very high levels of morbidity and mortality in intensive care units (Weinstein et al., 2005; Baker et al. 2017).”
BackgroundAnti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model
Erami, A. N., Rasooli, I., Jahangiri, A., & Astaneh, S. D. A. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105291 · Cited by 33
Hazen, J. E., Venanzio, G. D., Hultgren, S. J., & Feldman, M. F. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn8134 · Cited by 33
NK1.1+ cells regulate neutrophil migration in mice with Acinetobacter baumannii pneumonia
Tsuchiya, T., Nakao, N., Yamamoto, S., Hirai, Y., Miyamoto, K., & Tsujibo, H. (2011) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2011.00402.x · Cited by 33
Webster, T. J. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28191 · Cited by 33
“The two pathogens most commonly associated with VAP in pediatrics are Pseudomonas aeruginosa and Staphylococcus aureus.(5) One of the main sources of bacterial colonization within the airway is the endotracheal tube (ETT).”
Tai, K. P., Kamdar, K., Yamaki, J., Le, V. V., Tran, D., Tran, P. A., Selsted, M. E., Ouellette, A. J., & Wong‐Beringer, A. (2013) · Innate Immunity · doi:10.1177/1753425913514784 · Cited by 33
Kim, J.-H., Kim, T. S., Song, S. H., Choi, J., Han, S., Kim, D. Y., Kwon, S., Lee, E., Song, K., Choe, P. G., et al. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000678 · Cited by 33
Kohlenberg, A., Schwab, F., Geffers, C., Behnke, M., Rüden, H., & Gastmeier, P. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01879.x · Cited by 33
Minerdi, D., Zgrablic, I., Castrignanò, S., Catucci, G., Medana, C., Terlizzi, M. E., Gribaudo, G., Gilardi, G., & Sadeghi, S. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01088-15 · Cited by 32
Novel Bacterial Topoisomerase inhibitors (NBTIs) – A comprehensive review
Desai, J., Sachchidanand, S., Kumar, S., & Sharma, R. K. (2021) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2021.100017 · Cited by 32
Adaptation to an Amoeba Host Leads to Pseudomonas aeruginosa Isolates with Attenuated Virulence
Leong, W., Poh, W. H., Williams, J. G., Lutz, C., Hoque, M. M., Poh, Y., Yeo, B. K. Y., Chua, C., Givskov, M., Sanderson‐Smith, M. L., et al. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.02322-21 · Cited by 35
Metadata
- Authors
- Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 848-854
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151958462
- Cited by
- 1,404
- References
- 26
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 37 · 2023: 56 · 2022: 73 · 2021: 80 · 2020: 66 · 2019: 78 · 2018: 66 · 2017: 74 · 2016: 86 · 2015: 89 · 2014: 85 · 2013: 95 · 2012: 85
- FWCI
- 38.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial infections, Gram-negative bacilli, intensive care unit, surgical site infection, urinary tract infection, bloodstream infection, Acinetobacter, antimicrobial resistance, epidemiological trends
- MeSH terms
- Cross Infection, Gram-Negative Bacteria, Humans, National Health Programs, Population Surveillance, Surgical Wound Infection, Time Factors, United States, Urinary Tract Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.